Compare GNTA & SRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GNTA | SRBK |
|---|---|---|
| Founded | 2014 | 1887 |
| Country | Italy | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.0M | 123.7M |
| IPO Year | 2021 | N/A |
| Metric | GNTA | SRBK |
|---|---|---|
| Price | $1.33 | $15.82 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 100.9K | 37.8K |
| Earning Date | 03-30-2026 | 01-30-2026 |
| Dividend Yield | N/A | ★ 1.26% |
| EPS Growth | N/A | ★ 374.69 |
| EPS | N/A | ★ 0.54 |
| Revenue | N/A | ★ $31,130,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $29.31 |
| Revenue Growth | N/A | ★ 0.85 |
| 52 Week Low | $1.28 | $11.36 |
| 52 Week High | $10.00 | $17.11 |
| Indicator | GNTA | SRBK |
|---|---|---|
| Relative Strength Index (RSI) | 36.77 | 48.79 |
| Support Level | $1.28 | $16.12 |
| Resistance Level | $1.59 | $16.34 |
| Average True Range (ATR) | 0.19 | 0.39 |
| MACD | 0.03 | -0.14 |
| Stochastic Oscillator | 24.49 | 22.15 |
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
SR Bancorp Inc principal business is to acquire deposits from individuals and businesses in the communities surrounding offices and to use these deposits to fund loans.